Because of the involvement of α-synuclein in PD pathogenesis and its presence in the CSF, blood, and other body fluids, the biomarker potential of this protein has been examined extensively in PD as well as other synucleinopathies. The gene discussed is SNCA; the disease is Parkinson disease.